BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19349890)

  • 1. Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations.
    Goyal S; Gupta P; Ryan CM; Kazlas M; Noviski N; Sheridan RL
    J Burn Care Res; 2009; 30(3):437-49. PubMed ID: 19349890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis (Lyell syndrome).
    Roujeau JC; Chosidow O; Saiag P; Guillaume JC
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1039-58. PubMed ID: 2273103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis: a paradigm of critical illness.
    Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
    Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Biobrane in the treatment of toxic epidermal necrolysis.
    Kucan JO
    J Burn Care Rehabil; 1995; 16(3 Pt 1):324-7; discussion 327-8. PubMed ID: 7673317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis in children--an update.
    Ringheanu M; Laude TA
    Clin Pediatr (Phila); 2000 Dec; 39(12):687-94. PubMed ID: 11156065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis.
    Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F
    Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of toxic epidermal necrolysis in a pediatric burn center.
    Adzick NS; Kim SH; Bondoc CC; Quinby WC; Remensnyder JP
    Am J Dis Child; 1985 May; 139(5):499-502. PubMed ID: 3920898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced toxic epidermal necrolysis in children.
    Jones WG; Halebian P; Madden M; Finkelstein J; Goodwin CW
    J Pediatr Surg; 1989 Feb; 24(2):167-70. PubMed ID: 2724007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis.
    Hinc-Kasprzyk J; Polak-Krzemińska A; Ożóg-Zabolska I
    Anaesthesiol Intensive Ther; 2015; 47(3):257-62. PubMed ID: 26165242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis. A comprehensive approach. Multidisciplinary management in a burn center.
    Taylor JA; Grube B; Heimbach DM; Bergman AB
    Clin Pediatr (Phila); 1989 Sep; 28(9):404-7. PubMed ID: 2504529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lian BS; Lee HY
    Expert Opin Drug Saf; 2022 Aug; 21(8):1039-1046. PubMed ID: 35878014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis.
    Lacy JA
    Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Ferrandiz-Pulido C; Garcia-Patos V
    Arch Dis Child; 2013 Dec; 98(12):998-1003. PubMed ID: 23873883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis and Stevens-Johnson syndrome at the Prague Burn Centre 1998-2008.
    Zajicek R; Pintar D; Broz L; Suca H; Königova R
    J Eur Acad Dermatol Venereol; 2012 May; 26(5):639-43. PubMed ID: 21668825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic epidermal necrolysis: a review.
    Avakian R; Flowers FP; Araujo OE; Ramos-Caro FA
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):69-79. PubMed ID: 1880257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.